Last 12 months
Inside the activity.
0 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 25 |
| Dec 2025 | 0 | 4 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 16, 2020 Filed Jan 17, 2020 16:18 UTC |
BARUCH THOMAS RDirector
|
SaleCommon Stock | 10,000 | $18.61 | $186,090.00 |
DisclosureSEC source: 0001567619-20-001239 · doc1.xml · nonDerivative · entry 2 BARUCH THOMAS R · CIK 0001005563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,040 F1 · kind: The sales reported in this Form 4 were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.51 to $18.72, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 16:18 UTC |
BARUCH THOMAS RDirector
|
SaleCommon Stock | 10,000 | $18.68 | $186,816.00 |
DisclosureSEC source: 0001567619-20-001239 · doc1.xml · nonDerivative · entry 1 BARUCH THOMAS R · CIK 0001005563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,040 F1 · kind: The sales reported in this Form 4 were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.522 to $18.83, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 19, 2019 Filed Dec 20, 2019 17:07 UTC |
WOLF DENNIS PDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $3.62 | $0.00 |
DisclosureSEC source: 0001567619-19-023482 · doc1.xml · derivative · entry 3 WOLF DENNIS P · CIK 0001227560 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2022-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| December 19, 2019 Filed Dec 20, 2019 17:07 UTC |
WOLF DENNIS PDirector
|
SaleCommon Stock | 20,000 | $16.22 | $324,384.00 |
DisclosureSEC source: 0001567619-19-023482 · doc1.xml · nonDerivative · entry 2 WOLF DENNIS P · CIK 0001227560 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,177 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: This transaction was executed in multiple trades in prices ranging from $15.92 to $16.52, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| December 19, 2019 Filed Dec 20, 2019 17:07 UTC |
WOLF DENNIS PDirector
|
Exercise / conversionCommon Stock | 20,000 | $3.62 | $72,400.00 |
DisclosureSEC source: 0001567619-19-023482 · doc1.xml · nonDerivative · entry 1 WOLF DENNIS P · CIK 0001227560 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 21:10 UTC |
Dorgan Byron LDirector
|
SaleCommon Stock | 25,000 | $15.64 | $390,972.50 |
DisclosureSEC source: 0001567619-19-023067 · doc1.xml · nonDerivative · entry 1 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,540 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: This transaction was executed in multiple trades in prices ranging from $15.40 to $15.90, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| December 11, 2019 Filed Dec 12, 2019 16:10 UTC |
BARUCH THOMAS RDirector
|
SaleCommon Stock | 17,500 | $15.59 | $272,891.50 |
DisclosureSEC source: 0001567619-19-022979 · doc1.xml · nonDerivative · entry 2 BARUCH THOMAS R · CIK 0001005563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,040 F1 · kind: The sales reported in this Form 4 were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.43 to $15.76, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 10, 2019 Filed Dec 12, 2019 16:10 UTC |
BARUCH THOMAS RDirector
|
SaleCommon Stock | 17,500 | $15.61 | $273,236.25 |
DisclosureSEC source: 0001567619-19-022979 · doc1.xml · nonDerivative · entry 1 BARUCH THOMAS R · CIK 0001005563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,540 F1 · kind: The sales reported in this Form 4 were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.46 to $15.74, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 12, 2019 Filed Feb 13, 2020 16:36 UTC |
NICOLS JOHN JDirector · President and CEO
|
GiftCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-003341 · doc1.xml · nonDerivative · entry 1 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,022,679 F1 · kind: This transaction involved a gift of securities by the Reporting Person made on September 12, 2019. Read SEC document |
| September 06, 2019 Filed Sep 6, 2019 19:39 UTC |
KELLEY BERNARD JDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 16,666 | $0.00 Strike: $10.92 | $0.00 |
DisclosureSEC source: 0001567619-19-018012 · doc1.xml · derivative · entry 3 KELLEY BERNARD J · CIK 0001181179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,666 shares Expires 2020-02-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable. Read SEC document |
| September 06, 2019 Filed Sep 6, 2019 19:39 UTC |
KELLEY BERNARD JDirector
|
SaleCommon Stock | 14,684 | $13.87 | $203,677.36 |
DisclosureSEC source: 0001567619-19-018012 · doc1.xml · nonDerivative · entry 2 KELLEY BERNARD J · CIK 0001181179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,184 F1 · price: This transaction was executed in multiple trades in prices ranging from $13.76 to $14.03, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 06, 2019 Filed Sep 6, 2019 19:39 UTC |
KELLEY BERNARD JDirector
|
Exercise / conversionCommon Stock | 16,666 | $10.92 | $181,992.72 |
DisclosureSEC source: 0001567619-19-018012 · doc1.xml · nonDerivative · entry 1 KELLEY BERNARD J · CIK 0001181179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,868 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 06, 2019 Filed Sep 6, 2019 23:34 UTC |
Yang Patrick YDirector
|
PurchaseCommon Stock | 5,000 | $13.74 | $68,676.00 |
DisclosureSEC source: 0001567619-19-018011 · doc1.xml · nonDerivative · entry 2 Yang Patrick Y · CIK 0001309988 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,764 F2 · price: This transaction was executed in multiple trades in prices ranging from $13.7299 to $13.7358, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. Read SEC document |
| September 04, 2019 Filed Sep 6, 2019 23:34 UTC |
Yang Patrick YDirector
|
PurchaseCommon Stock | 3,000 | $13.62 | $40,846.80 |
DisclosureSEC source: 0001567619-19-018011 · doc1.xml · nonDerivative · entry 1 Yang Patrick Y · CIK 0001309988 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,764 F1 · price: This transaction was executed in multiple trades in prices ranging from $13.5999 to $13.6234, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 20:32 UTC |
Yang Patrick YDirector
|
PurchaseCommon Stock | 6,000 | $13.97 | $83,812.80 |
DisclosureSEC source: 0001567619-19-017888 · doc1.xml · nonDerivative · entry 1 Yang Patrick Y · CIK 0001309988 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,764 F1 · price: This transaction was executed in multiple trades in prices ranging from $13.96 to $13.9695, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 13:16 UTC |
Yang Patrick YDirector
|
PurchaseCommon Stock | 12,000 | $12.94 | $155,280.00 |
DisclosureSEC source: 0001567619-19-017555 · doc1.xml · nonDerivative · entry 1 Yang Patrick Y · CIK 0001309988 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,764 F1 · price: This transaction was executed in multiple trades in prices ranging from $12.80 to $13.04, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 16:20 UTC |
TAYLOR DEAN ROSS JRChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 42,285 | $0.00 Strike: $13.01 | $0.00 |
DisclosureSEC source: 0001567619-19-017470 · doc1.xml · derivative · entry 1 TAYLOR DEAN ROSS JR · CIK 0001646304 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,285 Underlying: Common Stock · 42,285 shares Expires 2029-08-20 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject thereto on August 19, 2020, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on August 19, 2023. Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 21:32 UTC |
NICOLS JOHN JDirector · President and CEO
|
PurchaseCommon Stock | 10,000 | $13.30 | $133,000.00 |
DisclosureSEC source: 0001567619-19-017500 · doc1.xml · nonDerivative · entry 1 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,082,679 F1 · kind: Given the reporting person's sale of (i) 15,072 shares of CDXS common stock in a transaction that was executed in multiple trades in prices ranging from $20.90 to $21.34, inclusive, on March 18, 2019 and (ii) 40,000 shares of CDXS common stock in a transaction that was executed in multiple trades in prices ranging from $20.62 to $20.94, inclusive, on March 19, 2019, this purchase transaction is subject to the short-swing provisions under Section 16(b) of the Securities Exchange Act of 1934. Accordingly, the reporting person has agreed to pay to CDXS, $76,736.90 representing the full amount of profit realized in connection with this short-swing transaction, less transaction costs. Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 21:32 UTC |
NICOLS JOHN JDirector · President and CEO
|
PurchaseCommon Stock | 10,000 | $13.30 | $133,000.00 |
DisclosureSEC source: 0001567619-19-017501 · doc1.xml · nonDerivative · entry 1 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,082,679 F1 · kind: Given the reporting person's sale of (i) 15,072 shares of CDXS common stock in a transaction that was executed in multiple trades in prices ranging from $20.90 to $21.34, inclusive, on March 18, 2019 and (ii) 40,000 shares of CDXS common stock in a transaction that was executed in multiple trades in prices ranging from $20.62 to $20.94, inclusive, on March 19, 2019, this purchase transaction is subject to the short-swing provisions under Section 16(b) of the Securities Exchange Act of 1934. Accordingly, the reporting person has agreed to pay to CDXS, $76,736.90 representing the full amount of profit realized in connection with this short-swing transaction, less transaction costs. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 16:10 UTC |
BARUCH THOMAS RDirector
|
GrantCommon Stock | 4,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013331 · doc1.xml · nonDerivative · entry 1 BARUCH THOMAS R · CIK 0001005563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,040 F1 · shares: Restricted stock. The shares vest on the earlier of June 11, 2020 or the date of the Issuer's 2020 annual meeting of stockholders. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 16:13 UTC |
KELLEY BERNARD JDirector
|
GrantCommon Stock | 4,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013336 · doc1.xml · nonDerivative · entry 1 KELLEY BERNARD J · CIK 0001181179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,202 F1 · shares: Restricted stock. The shares vest on the earlier of June 11, 2020 or the date of the Issuer's 2020 annual meeting of stockholders. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 20:13 UTC |
Smith David VDirector
|
GrantCommon Stock | 4,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013338 · doc1.xml · nonDerivative · entry 1 Smith David V · CIK 0001229447 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,947 F1 · shares: Restricted stock. The shares vest on the earlier of June 11, 2020 or the date of the Issuer's 2020 annual meeting of stockholders. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 16:14 UTC |
WOLF DENNIS PDirector
|
GrantCommon Stock | 4,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013339 · doc1.xml · nonDerivative · entry 1 WOLF DENNIS P · CIK 0001227560 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,177 F1 · shares: Restricted stock. The shares vest on the earlier of June 11, 2020 or the date of the Issuer's 2020 annual meeting of stockholders. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 20:14 UTC |
Yang Patrick YDirector
|
GrantCommon Stock | 4,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013341 · doc1.xml · nonDerivative · entry 1 Yang Patrick Y · CIK 0001309988 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,764 F1 · shares: Restricted stock. The shares vest on the earlier of June 11, 2020 or the date of the Issuer's 2020 annual meeting of stockholders. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 20:12 UTC |
Dorgan Byron LDirector
|
GrantCommon Stock | 4,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013333 · doc1.xml · nonDerivative · entry 1 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,540 F1 · shares: Restricted stock. The shares vest on the earlier of June 11, 2020 or the date of the Issuer's 2020 annual meeting of stockholders. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 20:12 UTC |
Glaub Kathleen SeredaDirector
|
GrantCommon Stock | 4,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013334 · doc1.xml · nonDerivative · entry 1 Glaub Kathleen Sereda · CIK 0001619612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,481 F1 · shares: Restricted stock. The shares vest on the earlier of June 11, 2020 or the date of the Issuer's 2020 annual meeting of stockholders. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 20:11 UTC |
Cheng Pam P.Director
|
GrantCommon Stock | 4,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013332 · doc1.xml · nonDerivative · entry 1 Cheng Pam P. · CIK 0001623746 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,589 F1 · shares: Restricted stock. The shares vest on the earlier of June 11, 2020 or the date of the Issuer's 2020 annual meeting of stockholders. Read SEC document |
| May 14, 2019 Filed May 15, 2019 20:23 UTC |
Lalonde JamesSVP, R&D
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,378 | $0.00 Strike: $7.46 | $0.00 |
DisclosureSEC source: 0001567619-19-011235 · doc1.xml · derivative · entry 6 Lalonde James · CIK 0001599677 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,378 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Includes 1,073 shares held in constructive trust for the sole benefit of the reporting person's ex-spouse pursuant to terms of a marital settlement agreement. The shares held in trust for the ex-spouse are no longer beneficially owned by the reporting person. F5 · derivative.exercise_date: The option is fully vested and exercisable. F6 · derivative.expiration_date: The option was exercised by the Reporting Person ahead of its expiration on June 1, 2019. F3 · derivative.underlying_shares: Includes 1,073 shares held in constructive trust for the sole benefit of the reporting person's ex-spouse pursuant to terms of a marital settlement agreement. The shares held in trust for the ex-spouse are no longer beneficially owned by the reporting person. Read SEC document |
| May 14, 2019 Filed May 15, 2019 20:23 UTC |
Lalonde JamesSVP, R&D
|
SaleCommon Stock | 2,378 | $18.95 | $45,059.53 |
DisclosureSEC source: 0001567619-19-011235 · doc1.xml · nonDerivative · entry 4 Lalonde James · CIK 0001599677 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,402 F3 · shares: Includes 1,073 shares held in constructive trust for the sole benefit of the reporting person's ex-spouse pursuant to terms of a marital settlement agreement. The shares held in trust for the ex-spouse are no longer beneficially owned by the reporting person. F4 · price: This transaction was executed in multiple trades in prices ranging from $18.90 to $19.00, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price with the range set forth in this footnote. Read SEC document |
| May 14, 2019 Filed May 15, 2019 20:23 UTC |
Lalonde JamesSVP, R&D
|
Exercise / conversionCommon Stock | 2,378 | $7.46 | $17,739.88 |
DisclosureSEC source: 0001567619-19-011235 · doc1.xml · nonDerivative · entry 3 Lalonde James · CIK 0001599677 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Includes 1,073 shares held in constructive trust for the sole benefit of the reporting person's ex-spouse pursuant to terms of a marital settlement agreement. The shares held in trust for the ex-spouse are no longer beneficially owned by the reporting person. F3 · balance_after: Includes 1,073 shares held in constructive trust for the sole benefit of the reporting person's ex-spouse pursuant to terms of a marital settlement agreement. The shares held in trust for the ex-spouse are no longer beneficially owned by the reporting person. Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:23 UTC |
Lalonde JamesSVP, R&D
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,621 | $0.00 Strike: $7.46 | $0.00 |
DisclosureSEC source: 0001567619-19-011235 · doc1.xml · derivative · entry 5 Lalonde James · CIK 0001599677 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,378 Underlying: Common Stock · 17,621 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Includes 7,949 shares held in constructive trust for the sole benefit of the reporting person's ex-spouse pursuant to terms of a marital settlement agreement. The shares held in trust for the ex-spouse are no longer beneficially owned by the reporting person. F5 · derivative.exercise_date: The option is fully vested and exercisable. F6 · derivative.expiration_date: The option was exercised by the Reporting Person ahead of its expiration on June 1, 2019. F1 · derivative.underlying_shares: Includes 7,949 shares held in constructive trust for the sole benefit of the reporting person's ex-spouse pursuant to terms of a marital settlement agreement. The shares held in trust for the ex-spouse are no longer beneficially owned by the reporting person. F3 · balance_after: Includes 1,073 shares held in constructive trust for the sole benefit of the reporting person's ex-spouse pursuant to terms of a marital settlement agreement. The shares held in trust for the ex-spouse are no longer beneficially owned by the reporting person. Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:23 UTC |
Lalonde JamesSVP, R&D
|
SaleCommon Stock | 17,621 | $18.61 | $327,955.00 |
DisclosureSEC source: 0001567619-19-011235 · doc1.xml · nonDerivative · entry 2 Lalonde James · CIK 0001599677 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,402 F1 · shares: Includes 7,949 shares held in constructive trust for the sole benefit of the reporting person's ex-spouse pursuant to terms of a marital settlement agreement. The shares held in trust for the ex-spouse are no longer beneficially owned by the reporting person. F2 · price: This transaction was executed in multiple trades in prices ranging from $18.50 to $18.84, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price with the range set forth in this footnote. Read SEC document |
| May 13, 2019 Filed May 15, 2019 20:23 UTC |
Lalonde JamesSVP, R&D
|
Exercise / conversionCommon Stock | 17,621 | $7.46 | $131,452.66 |
DisclosureSEC source: 0001567619-19-011235 · doc1.xml · nonDerivative · entry 1 Lalonde James · CIK 0001599677 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Includes 7,949 shares held in constructive trust for the sole benefit of the reporting person's ex-spouse pursuant to terms of a marital settlement agreement. The shares held in trust for the ex-spouse are no longer beneficially owned by the reporting person. F1 · balance_after: Includes 7,949 shares held in constructive trust for the sole benefit of the reporting person's ex-spouse pursuant to terms of a marital settlement agreement. The shares held in trust for the ex-spouse are no longer beneficially owned by the reporting person. Read SEC document |
| March 21, 2019 Filed Mar 22, 2019 18:25 UTC |
SANGSTER GORDONSVP & Chief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001567619-19-007501 · doc1.xml · derivative · entry 6 SANGSTER GORDON · CIK 0001243383 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: Common Stock · 40,000 shares Expires 2026-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option currently vests monthly, such that the option will be fully vested and exercisable on February 19, 2020. Read SEC document |
| March 21, 2019 Filed Mar 22, 2019 18:25 UTC |
SANGSTER GORDONSVP & Chief Financial Officer
|
SaleCommon Stock | 40,000 | $20.91 | $836,204.00 |
DisclosureSEC source: 0001567619-19-007501 · doc1.xml · nonDerivative · entry 4 SANGSTER GORDON · CIK 0001243383 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,453 F1 · shares: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 28, 2018. F3 · price: This transaction was executed in multiple trades in prices ranging from $20.73 to $21.24, inclusive. The price report in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 21, 2019 Filed Mar 22, 2019 18:25 UTC |
SANGSTER GORDONSVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 40,000 | $4.10 | $164,000.00 |
DisclosureSEC source: 0001567619-19-007501 · doc1.xml · nonDerivative · entry 3 SANGSTER GORDON · CIK 0001243383 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 18:25 UTC |
SANGSTER GORDONSVP & Chief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $3.39 | $0.00 |
DisclosureSEC source: 0001567619-19-007501 · doc1.xml · derivative · entry 5 SANGSTER GORDON · CIK 0001243383 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 40,000 shares Expires 2025-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option is fully vested and exercisable. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 18:25 UTC |
SANGSTER GORDONSVP & Chief Financial Officer
|
SaleCommon Stock | 40,000 | $20.85 | $834,012.00 |
DisclosureSEC source: 0001567619-19-007501 · doc1.xml · nonDerivative · entry 2 SANGSTER GORDON · CIK 0001243383 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,453 F1 · shares: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 28, 2018. F2 · price: This transaction was executed in multiple trades in prices ranging from $20.53 to $21.13, inclusive. The price report in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 20, 2019 Filed Mar 22, 2019 18:25 UTC |
SANGSTER GORDONSVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 40,000 | $3.39 | $135,600.00 |
DisclosureSEC source: 0001567619-19-007501 · doc1.xml · nonDerivative · entry 1 SANGSTER GORDON · CIK 0001243383 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2019 Filed Mar 20, 2019 17:30 UTC |
NICOLS JOHN JDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $3.46 | $0.00 |
DisclosureSEC source: 0001567619-19-007317 · doc1.xml · derivative · entry 6 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,385 Underlying: Common Stock · 40,000 shares Expires 2022-06-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 19, 2019 Filed Mar 20, 2019 17:30 UTC |
NICOLS JOHN JDirector · President and CEO
|
SaleCommon Stock | 40,000 | $20.79 | $831,504.00 |
DisclosureSEC source: 0001567619-19-007317 · doc1.xml · nonDerivative · entry 4 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,072,679 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. F3 · price: This transaction was executed in multiple trades in prices ranging from $20.62 to $20.94, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 19, 2019 Filed Mar 20, 2019 17:30 UTC |
NICOLS JOHN JDirector · President and CEO
|
Exercise / conversionCommon Stock | 40,000 | $3.46 | $138,400.00 |
DisclosureSEC source: 0001567619-19-007317 · doc1.xml · nonDerivative · entry 3 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,112,679 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:30 UTC |
NICOLS JOHN JDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,072 | $0.00 Strike: $3.46 | $0.00 |
DisclosureSEC source: 0001567619-19-007317 · doc1.xml · derivative · entry 5 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,385 Underlying: Common Stock · 15,072 shares Expires 2022-06-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. F4 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:30 UTC |
NICOLS JOHN JDirector · President and CEO
|
SaleCommon Stock | 15,072 | $20.95 | $315,716.20 |
DisclosureSEC source: 0001567619-19-007317 · doc1.xml · nonDerivative · entry 2 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,072,679 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. F2 · price: This transaction was executed in multiple trades in prices ranging from $20.90 to $21.34, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 18, 2019 Filed Mar 20, 2019 17:30 UTC |
NICOLS JOHN JDirector · President and CEO
|
Exercise / conversionCommon Stock | 15,072 | $3.46 | $52,149.12 |
DisclosureSEC source: 0001567619-19-007317 · doc1.xml · nonDerivative · entry 1 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,087,751 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 29, 2017. Read SEC document |
| February 26, 2019 Filed Feb 27, 2019 16:07 UTC |
WOLF DENNIS PDirector
|
SaleCommon Stock | 9,000 | $21.96 | $197,640.00 |
DisclosureSEC source: 0001567619-19-005477 · doc1.xml · nonDerivative · entry 1 WOLF DENNIS P · CIK 0001227560 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,230 F1 · kind: The sales reported in this Form 4 were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades in prices ranging from $21.81 to $22.12, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 20:07 UTC |
SANGSTER GORDONSVP & Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $21.80 | $0.00 |
DisclosureSEC source: 0001567619-19-005298 · doc1.xml · derivative · entry 2 SANGSTER GORDON · CIK 0001243383 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2029-02-20 F2 · derivative.exercise_date: Option vests with respect to 25% of the shares subject thereto on February 20, 2020, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 20, 2023. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 20:07 UTC |
SANGSTER GORDONSVP & Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 112,100 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001567619-19-005298 · doc1.xml · derivative · entry 1 SANGSTER GORDON · CIK 0001243383 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,100 Underlying: Common Stock · 112,100 shares Expires 2028-02-20 F1 · shares: On February 20, 2018, the issuer granted the reporting person an option that commences vesting in respect of a number of shares of the issuer's common stock determined based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2018 with any remaining shares forfeited. On February 20, 2019, the compensation committee of the issuer's board of directors certified achievement of the performance criteria at 118% of the target level, which will result in the vesting of the option with respect to 56,050 shares on March 5, 2019 and 56,050 shares on March 5, 2020, in each case subject to the reporting person's continued service to the issuer through such vesting date. F1 · derivative.exercise_date: On February 20, 2018, the issuer granted the reporting person an option that commences vesting in respect of a number of shares of the issuer's common stock determined based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2018 with any remaining shares forfeited. On February 20, 2019, the compensation committee of the issuer's board of directors certified achievement of the performance criteria at 118% of the target level, which will result in the vesting of the option with respect to 56,050 shares on March 5, 2019 and 56,050 shares on March 5, 2020, in each case subject to the reporting person's continued service to the issuer through such vesting date. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 20:09 UTC |
NICOLS JOHN JDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $21.80 | $0.00 |
DisclosureSEC source: 0001567619-19-005300 · doc1.xml · derivative · entry 2 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2029-02-20 F2 · derivative.exercise_date: Option vests with respect to 25% of the shares subject thereto on February 20, 2020, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 20, 2023. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 20:09 UTC |
NICOLS JOHN JDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 383,500 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001567619-19-005300 · doc1.xml · derivative · entry 1 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 383,500 Underlying: Common Stock · 383,500 shares Expires 2028-02-20 F1 · shares: On February 20, 2018, the issuer granted the reporting person an option that commences vesting in respect of a number of shares of the issuer's common stock determined based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2018 with any remaining shares forfeited. On February 20, 2019, the compensation committee of the issuer's board of directors certified achievement of the performance criteria at 118% of the target level, which will result in the vesting of the option with respect to 191,750 shares on March 5, 2019 and 191,750 shares on March 5, 2020, in each case subject to the reporting person's continued service to the issuer through such vesting date. F1 · derivative.exercise_date: On February 20, 2018, the issuer granted the reporting person an option that commences vesting in respect of a number of shares of the issuer's common stock determined based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2018 with any remaining shares forfeited. On February 20, 2019, the compensation committee of the issuer's board of directors certified achievement of the performance criteria at 118% of the target level, which will result in the vesting of the option with respect to 191,750 shares on March 5, 2019 and 191,750 shares on March 5, 2020, in each case subject to the reporting person's continued service to the issuer through such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.